Anatomical Classifications of Inferior Mesenteric Artery (IMA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03515850 |
Recruitment Status :
Recruiting
First Posted : May 4, 2018
Last Update Posted : May 4, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Colorectal Cancer |
Study Type : | Observational |
Estimated Enrollment : | 500 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Clinical Trial of Anatomical Classifications of Inferior Mesenteric Artery in Laparoscopic Rectal Resection Surgery |
Actual Study Start Date : | January 5, 2018 |
Estimated Primary Completion Date : | July 1, 2019 |
Estimated Study Completion Date : | January 30, 2021 |
- classifications vascular branches of IMA [ Time Frame: 3years ]based on the positon of LCA that conjoin the IMA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients who undergoing laparoscopic rectal cancer surgery.
- Pathology: adenocarcinoma or huge adenomas proven by colonoscopic biopsy.
- Localization: tumor located between distal sigmoid colon and anal canal.
- Patients have to be aware of the aim of the trial, and have signed the informed consent.
Exclusion Criteria:
- History of any gastrointestinal surgery.
- Patients with emergent surgery.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03515850
Contact: Tang Bo, M.D | +862368754167 | tangtbo@sina.com | |
Contact: Li Chuan, M.D | +86-18323479228 | yupeiwu1961@aliyun.com |
China | |
General Surgery Center of PLA | Recruiting |
Chongqing, China, 400038 | |
Contact: Yu Peiwu, M.D/Ph.D +862368754167 yupeiwu01@sina.com |
Responsible Party: | Li Chuan, Southwest Hospital, China |
ClinicalTrials.gov Identifier: | NCT03515850 |
Other Study ID Numbers: |
Southwest-IMA-rectal |
First Posted: | May 4, 2018 Key Record Dates |
Last Update Posted: | May 4, 2018 |
Last Verified: | April 2018 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |